NASDAQ:CYTO - Nasdaq - BMG0360L1349 - Common Stock - Currency: USD
TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 62.75K | 188.23K | 310.00K | 60.00K | 0.00 | |||
Cost Of Goods | N/A | 204.04K | 510.00K | 260.00K | N/A | |||
Gross Profit | N/A | -15.81K | -210.00K | -200.00K | N/A | |||
Operating Expenses | 567.13K | 1.98M | 12.60M | 13.06M | 5.28M | |||
Research and Development | 969.28K | 1.70M | 7.20M | 6.78M | 2.81M | |||
Selling, General, and Administrative Expenses | -403.89K | 443.17K | 6.03M | 6.44M | 2.63M | |||
Operating Income | -472.63K | -2.00M | -12.80M | -13.26M | -5.28M | |||
Interest Income/Expense | 394.15K | -163.84K | -410.00K | -270.00K | -2.72M | |||
Other Income/Expense | N/A | -10.97K | 0.00 | 0.00 | -220.00K | |||
Non Recurring Items | N/A | -64.71K | -13.33M | -3.51M | N/A | |||
Income Before Taxes | -137.49K | -2.23M | -26.54M | -17.04M | -8.22M | |||
Income Tax | N/A | -117.63K | -10.00K | 20.00K | -20.00K | |||
Net Income | -7.24K | -2.12M | -26.53M | -17.06M | -8.20M | |||
EBITDA | -357.88K | -1.88M | -12.68M | -13.18M | -5.26M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | 0.83 | -1.43 | -29.15 | -25.84 | -27.33 | |||
Non GAAP EPS | N/A | N/A | N/A | N/A | N/A | |||
Statistics | ||||||||
Gross Profit Margin | N/A | -8.40% | -67.74% | -333.33% | N/A | |||
Profit Margin | -11.54% | -1124.78% | -8558.06% | -28433.33% | N/A | |||
Operating Profit Margin | -753.22% | -1060.03% | -4129.03% | -22100.00% | N/A |
All data in USD